Investigation Overview
December 18, 2013 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Solta Medical Inc (NASDAQ:SLTM) shares, was announced concerning whether the takeover of Solta Medical Inc by Valeant Pharmaceuticals International. for $2.92 per share is unfair to NASDAQ:SLTM stockholders. The investigation by a law firm concerns whether certain offic...
You must register (for free) or login to view the entire investigation.